These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6092431)

  • 1. Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay.
    Venkitaraman AR; Seigneurin JM; Baccard M; Lenoir GM; John TJ
    J Clin Microbiol; 1984 Sep; 20(3):582-3. PubMed ID: 6092431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions].
    Reis AD; Pannuti CS; de Souza VA
    Rev Soc Bras Med Trop; 2003; 36(3):317-20. PubMed ID: 12908030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age of infection with varicella-zoster virus in St Lucia, West Indies.
    Garnett GP; Cox MJ; Bundy DA; Didier JM; St Catharine J
    Epidemiol Infect; 1993 Apr; 110(2):361-72. PubMed ID: 8386097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus.
    Demmler GJ; Steinberg SP; Blum G; Gershon AA
    J Infect Dis; 1988 Jan; 157(1):211-2. PubMed ID: 2826610
    [No Abstract]   [Full Text] [Related]  

  • 5. Varicella-zoster virus prevalence in Japan: no significant change in a decade.
    Taylor-Wiedeman J; Yamashita K; Miyamura K; Yamazaki S
    Jpn J Med Sci Biol; 1989 Feb; 42(1):1-11. PubMed ID: 2550689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin subclass antibodies to varicella-zoster virus.
    Asano Y; Hiroishi Y; Itakura N; Hirose S; Kajita Y; Nagai T; Yazaki T; Takahashi M
    Pediatrics; 1987 Dec; 80(6):933-6. PubMed ID: 2825110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus.
    Shanley J; Myers M; Edmond B; Steele R
    J Clin Microbiol; 1982 Feb; 15(2):208-11. PubMed ID: 6279689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody class capture assays for varicella-zoster virus.
    Forghani B; Myoraku CK; Dupuis KW; Schmidt NJ
    J Clin Microbiol; 1984 May; 19(5):606-9. PubMed ID: 6330163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass distribution among antibodies to varicella-zoster virus in human varicella/zoster immunoglobulin preparations and the corresponding donor plasma.
    Møyner K; Michaelsen TE
    J Biol Stand; 1988 Jul; 16(3):157-64. PubMed ID: 2844824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to varicella-zoster virus and the role of antibody in host defense.
    Gershon AA; Steinberg SP
    Am J Med Sci; 1981; 282(1):12-7. PubMed ID: 6267940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.
    Lolekha S; Tanthiphabha W; Sornchai P; Kosuwan P; Sutra S; Warachit B; Chup-Upprakarn S; Hutagalung Y; Weil J; Bock HL
    Am J Trop Med Hyg; 2001; 64(3-4):131-6. PubMed ID: 11442207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of antibodies to varicella-zoster virus in leukemic patients: comparison of commercial methods of enzyme-immunoassay and fluoroimmunoassay.
    de Ory F; Echevarria JM; Domingo CJ
    Diagn Microbiol Infect Dis; 1988 May; 10(1):61-4. PubMed ID: 2844470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of varicella in children from Spain.
    Cilla Eguiluz G; Perez Trallero E; García Arenzana JM
    J Infect Dis; 1987 Nov; 156(5):851. PubMed ID: 2821130
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
    Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.